DBVT logo

DBV Technologies SA (DBVT) Company Overview

Profile

Full Name:

DBV Technologies S.A.

Sector:

Healthcare

Industry:

Biotechnology

Country:

France

IPO:

October 22, 2014

Indexes:

Not included

Website:

http://www.dbv-technologies.com

Description:

DBV Technologies SA is a biopharmaceutical company focused on developing innovative treatments for food allergies. They use a unique technology called Viaskin, which delivers therapies through the skin, aiming to improve the lives of patients with allergies, particularly peanut allergies.

Key Details

Price

$4.45

Market Cap

$91.30 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$3.80(+38.71% YoY)

PE Ratio

-

Annual ROE

-51.88%

Annual Debt To Equity

0.05

Beta

2.12

Events Calendar

Earnings

Next earnings date:

Mar 7, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 29, 2024

Analyst ratings

Recent major analysts updates

Jan 10, 25 JMP Securities
Market Outperform
Dec 10, 24 JMP Securities
Market Outperform
Oct 24, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jul 31, 24 JMP Securities
Market Outperform
May 8, 24 HC Wainwright & Co.
Buy
Feb 21, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Nov 2, 23 Goldman Sachs
Sell
Aug 1, 23 JMP Securities
Market Outperform

Screeners with DBVT included

Growing Shares Outstanding
Stocks with high beta
Most recommended stocks
Best performing stocks last 3 months
Earnings next week
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$4.45
DBVT price is $4.45

Price All-time High

$98.72
DBVT price is currently -95.49% below its historical high of $98.72

Price Analysts Target

$22.05
DBVT price is currently -79.82% lower than the consensus analysts' forecast

Price Most Recent Change

+7.23%
DBVT price was up +7.23% on Feb 28, 2025

Price YTD Change

+44.43%
DBVT price is up +44.43% since January 1st

Price 3-Year Change

+66.04%
DBVT price is up +66.04% over the past 3 years

Market cap

Market Cap

$91.30 M
DBVT market capitalization is $91.30 million

Market Cap 3-Year Change

+210.15%
DBVT market capitalization is up +210.15% over the past 3 years

Market Cap All-time High

$487.75 M
DBVT market capitalization is currently -81.28% below its historical high of $487.75 million

Market Cap Sector Rank

44.82%
DBVT market capitalization is higher than 44.82% of companies in Healthcare sector

Technical

Beta

2.12
DBVT beta is 2.12

200-day SMA

$1.81
DBVT price is currently +146.22% above its 200-day simple moving average

14-day RSI

55.96
DBVT 14-day relative strength index is 55.96

30-day Relative Volume

0.58
DBVT 30-day relative volume is 0.58

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
DBVT annual revenue value is unknown

Annual Revenue Analysts Estimate

$4.59 M
DBVT annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
DBVT annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
DBVT annual revenue is unknown

Profit

Annual Gross Profit

-
DBVT annual gross profit value is unknown

Annual Gross Margin

-
DBVT annual gross profit margin value is unknown

Annual Operating Profit

-$76.53 M
DBVT annual operating income is -$76.53 million

Annual Operating Margin

-
DBVT annual operating profit margin value is unknown

Annual Net Income

-$72.73 M
DBVT annual net profit is -$72.73 million

Annual Net Margin

-
DBVT annual net profit margin value is unknown

EPS

Annual EPS

-$3.80
DBVT annual earnings per share is -$3.80

Annual EPS Analysts Estimate

-$1.13
DBVT annual earnings per share is currently +235.39% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+38.71%
DBVT annual earnings per share is up +38.71% year-on-year

Annual EPS Sector Rank

27.64%
DBVT annual earnings per share is higher than 27.64% of companies in Healthcare sector

ROA & ROE

Annual ROA

-39.74%
DBVT annual return on assets is -39.74%

Annual ROE

-51.88%
DBVT annual return on equity is -51.88%

EBIT & EBITDA

Annual EBIT

-$76.53 M
DBVT annual earnings before interest & taxes is -$76.53 million

Annual EBITDA

-$67.37 M
DBVT annual EBITDA is -$67.37 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
DBVT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
DBVT price to earnings ratio is unknown

PB Ratio

PB Ratio

1.69
DBVT price to book ratio is 1.69

PB Ratio Sector Rank

55.33%
DBVT price to book ratio is higher than 55.33% of companies in Healthcare sector

PS Ratio

PS Ratio

-
DBVT price to sales ratio value is unknown

PS Ratio Sector Rank

-
DBVT price to sales ratio is unknown

Enterprise value

Enterprise Value

$52.97 M
DBVT enterprise value is $52.97 million

Enterprise Value Sector Rank

41.02%
DBVT enterprise value is higher than 41.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.55
DBVT EV/EBITDA is -0.55

EV/EBITDA Sector Rank

53.76%
DBVT EV/EBITDA is higher than 53.76% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.26
DBVT annual current ratio is 4.26

Annual Quick Ratio

-
DBVT annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.05
DBVT annual debt to equity ratio is 0.05

Annual Interest Coverage Ratio

-
DBVT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DBVT piotroski f-score value is unknown

Altman Z-Score

-
DBVT altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$182.99 M
DBVT annual total assets is $182.99 million

Annual Non Current Assets

$24.07 M
DBVT annual long term assets is $24.07 million

Annual Current Assets

$158.91 M
DBVT annual total current assets is $158.91 million

Annual Cash & Cash Equivalents

$141.37 M
DBVT annual cash & cash equivalents is $141.37 million

Equity

Annual Book Value

$140.19 M
DBVT annual book value is $140.19 million

Annual Working Capital

$121.58 M
DBVT annual working capital is $121.58 million

Liabilities

Annual Total Liabilities

$42.80 M
DBVT annual total liabilities is $42.80 million

Annual Total Long Term Liabilities

$5.46 M
DBVT annual total long term liabilities is $5.46 million

Annual Current Liabilities

$37.34 M
DBVT annual total current liabilities is $37.34 million

Annual Accounts Payable

$23.30 M
DBVT annual accounts payable is $23.30 million

Debt

Annual Total Debt

$6.55 M
DBVT annual total debt is $6.55 million

Annual Total Debt 1-Year Change

+57.83%
DBVT annual total debt is up +57.83% year-on-year

Annual Long Term Debt

$4.53 M
DBVT annual long term debt is $4.53 million

Annual Short Term Debt

$2.03 M
DBVT annual short term debt is $2.03 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$76.53 M
DBVT annual total expenses is $76.53 million

Annual Operating Expenses

$76.53 M
DBVT annual total operating expenses is $76.53 million

Annual Cost Of Goods Sold

-
DBVT annual cost of goods sold value is unknown

Annual SGA

$22.88 M
DBVT annual SGA is $22.88 million

Annual D&A

-$14.00 M
DBVT annual depreciation & amortization is -$14.00 million

Annual Interest Expense

-
DBVT annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$79.65 M
DBVT annual cash flow from operations is -$79.65 million

Annual CFO 1-Year Change

-43.09%
DBVT annual cash flow from operations is down -43.09% year-on-year

Annual CFI

-$808.00 K
DBVT annual cash flow from investing activities is -$808.00 thousand

Annual CFI 1-Year Change

-708%
DBVT annual cash flow from investing activities is down -708% year-on-year

Annual CFF

$6.77 M
DBVT annual cash flow from financing activities is $6.77 million

Annual CFF 1-Year Change

-96.51%
DBVT annual cash flow from financing activities is down -96.51% year-on-year

Free CashFlow

Annual FCF

-$80.33 M
DBVT annual free cash flow is -$80.33 million

Annual FCF 1-Year Change

-42.38%
DBVT annual free cash flow is down -42.38% year-on-year

CAPEX

Annual CAPEX

-
DBVT annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
DBVT annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

ADAG logo
Adagene (ADAG)
PETS logo
PetMed Express (PETS)
SY logo
So-Young International (SY)
CRBP logo
Corbus Pharmaceuticals Holdings (CRBP)
Elicio Therapeutics (ELTX)
MIST logo
Milestone Pharmaceuticals (MIST)
Alpha Cognition (ACOG)
CAMP logo
CAMP4 Therapeutics (CAMP)
CABA logo
Cabaletta Bio (CABA)

FAQ

  • What is the ticker symbol for DBV Technologies SA?
  • Does DBV Technologies SA pay dividends?
  • What sector is DBV Technologies SA in?
  • What industry is DBV Technologies SA in?
  • What country is DBV Technologies SA based in?
  • When did DBV Technologies SA go public?
  • Is DBV Technologies SA in the S&P 500?
  • Is DBV Technologies SA in the NASDAQ 100?
  • Is DBV Technologies SA in the Dow Jones?
  • When was DBV Technologies SA's last earnings report?
  • When does DBV Technologies SA report earnings?
  • Should I buy DBV Technologies SA stock now?

What is the ticker symbol for DBV Technologies SA?

The ticker symbol for DBV Technologies SA is NASDAQ:DBVT

Does DBV Technologies SA pay dividends?

No, DBV Technologies SA does not pay dividends

What sector is DBV Technologies SA in?

DBV Technologies SA is in the Healthcare sector

What industry is DBV Technologies SA in?

DBV Technologies SA is in the Biotechnology industry

What country is DBV Technologies SA based in?

DBV Technologies SA is headquartered in France

When did DBV Technologies SA go public?

DBV Technologies SA's initial public offering (IPO) was on October 22, 2014

Is DBV Technologies SA in the S&P 500?

No, DBV Technologies SA is not included in the S&P 500 index

Is DBV Technologies SA in the NASDAQ 100?

No, DBV Technologies SA is not included in the NASDAQ 100 index

Is DBV Technologies SA in the Dow Jones?

No, DBV Technologies SA is not included in the Dow Jones index

When was DBV Technologies SA's last earnings report?

DBV Technologies SA's most recent earnings report was on Nov 6, 2024

When does DBV Technologies SA report earnings?

The next expected earnings date for DBV Technologies SA is Mar 7, 2025

Should I buy DBV Technologies SA stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions